Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Joe Giordano
Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q2 (8 quarters).
- Questions
- 87on tracked calls
- Challenge rate
- 18%16 of 87 questions
- Companies
- 11questioned at least once
- Reporting periods
- 8with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 87 of 87 questions from 11 companies
IEXIDEX Corporation14 questions · 7 reporting periods · 7 of 14 challenging
Calendar 2026 Q2
how do you separate the strategic changes you've made internally in your go-to-market
Show response
Engaged the challenge head-on, arguing the solutions are newly developed from acquired assets at volumes and specifications that did not previously exist.
just given the magnitude of the orders in HST and you mentioned some of these larger orders looking for next year
Show response
Deliberately tempered extrapolation by sizing the visible portion as a narrow corridor, declining to frame a 2027 growth rate this early.
Calendar 2026 Q1
as you look back on the last couple of years with these businesses, what's like the takeaway in your head?
Show response
CEO framed the delayed adoption as a net positive creating a deep competitive moat. Mission-critical markets require trust-building which delays initial uptake but creates defensibility. Now at the table for future discussions with multiple business units providing depth. Trusted partner status enables compounding opportunity.
Given the orders here, why should the second half organic decelerate from the pace that we're on now?
Show response
CFO explained HST should continue at high single-digit to double-digit growth driven by order backlog. FMT had good Q1 performance with end of quarter stronger than beginning, but outlook kept flattish for the year given macro uncertainty and only one quarter of data.
Calendar 2025 Q4
how should we view this guide relative to those, like, you know, one Q4 q, progression differently than we did last year
Show response
CEO highlighted key difference from last year: HST backlog built over $100 million year-over-year, broadly applied across HST not just data centers. Materials processing, MSS, and MicroLam all contributing. Assurance levels quite a bit higher, especially in HST.
how large is that now? How large can it realistically get in, like, a year or two
Show response
CEO confirmed light capital intensity making critical subcomponents on existing equipment. Still rare to run more than two shifts. Manpower additions needed but nothing significant on capital. Managing data center opportunities at HST segment level for cross-IDEX coordination.
Calendar 2025 Q3
if you just like step back now, like after the -- and kind of take in the last year, 18 months or so, and you look at the deals you've done
Show response
CEO defended acquisition thesis: clear line of sight to growth areas, same engineering-first rapid-iteration IDEX DNA. Setting specification points in emerging industries for annuity streams. Different assets in clean rooms vs traditional manufacturing but same economic engine of criticality at low bill of materials price point.
are any of like your businesses do you think like structurally differently positioned in a world where policy is kind of here
Show response
CEO emphasized agility advantage. MSS data center applications didn't exist 1-1.5 years ago but teams won quickly through flat organization and autonomous decision rights. Life science tunability allows shifting from pressured academic to strong pharma. Localized business model protects from trade policy shifts.
Calendar 2025 Q2
does that kind of pivot to bolting on within kind of the context of IDEX? Does it get us into a situation where like there could be more of a cascading effect
Show response
CEO pushed back noting Mott's technology links across wide range of end markets from data center switching to life science. HST businesses in faster-growing emerging markets but not chasing one singularity. Technologies are very appropriable across multiple applications.
last quarter, I thought the messaging was more like we are confident in the margin path because of actions that we've already taken
Show response
CEO clarified Muon semi lithography customer initially talked inventory timing, now settled that things will be steady for a while. Rest of semi elsewhere not an issue. Mott acceleration time-out created physics problem for year-end production.
Calendar 2025 Q1
is there any sense of like rebranding companies as a like, go-to-market as one entity
Show response
CEO described hybrid approach: IDEX Health & Science and IDEX Fire & Safety branded at platform level while celebrating sub-brands. Customer-driven evolution where IDEX brand represents combined capability.
the updates that we've been getting on semi, is generally negative so far this earnings season. So just curious if there's any update
Show response
CEO acknowledged push-out in semiconductor capital equipment recovery. MRO side favorable with Mott adding gas filter consumables. CFO confirmed Mott and pharma/space have replaced semi dependence in H2 ramp.
Calendar 2024 Q4
on semi, I thought you said that it decelerated out of Q4, and now it sounds like that's a major part of the acceleration
Show response
CEO clarified sealing solutions (MRO) is positive while capital equipment faces discrete customer inventory adjustments in H1. Life science sees low to mid-single-digit lift offset by genomics funding uncertainty.
the projects that you got, the $40 million. Was that contemplated when you gave when you guys reported Q3
Show response
CFO confirmed projects were specifically called out in Q3 guidance. Exact language referenced sequential Q3-to-Q4 ramp being driven by project activity.
TDYTeledyne Technologies14 questions · 7 reporting periods · 1 of 14 challenging
Calendar 2026 Q2
how should we frame second half into '27 for a market that seems to be kind of hitting its stride here?
Show response
George said the oscilloscope business is healthy while Protocol was slower in H1 on PCI Express timing; expects full-year test and measurement around 3% with a stronger back half.
the fourth quarter, even if I take the high end of the full year, I mean, it's barely up like year-on-year
Show response
Robert acknowledged tough Q4 comps in Digital Imaging plus germanium/rare-earth and tariff risks, but said $30 million, $40 million of upside is possible and called conservatism prudent.
Calendar 2026 Q1
you had previously last quarter talked about your unmanned business, $500 million, growing about 10%. I think the general view is that feels pretty conservative given recent events. Just curious fo...
Show response
Black Hornet cumulative ~$500M. Rogue 1 first contracts growing. Gavia subsea vehicles for mine detection with European orders. Defense broadly approaching $2B or 30-35% of revenue. Management remains at $500M unmanned guidance but pockets growing faster.
Calendar 2025 Q4
Obviously, prices are up a ton, and I believe there would be applicability for you guys having to buy that across you know, whether it is instrumentation or T and M and elements of digital imaging.
Show response
No net risk from memory prices. Some T&M instrumentation uses memory, but memory/storage suppliers are large T&M customers, their incremental CapEx spending is higher-margin business for Teledyne.
can you just run us through the organic kind of by segment, what you are thinking for next year?
Show response
DI ~3.5%, A&D slightly higher, Instruments ~3.5-4%. All segments 3.5-4% organic. No segment expected to decline. Don't see themselves as target of defense company restrictions, primarily commercial company with 30% defense. Only $1.2B buybacks in 26-year history.
Calendar 2025 Q3
we've been talking about $450 million across all unmanned. It feels like -- kind of for a while, it feels like a little bit of a dated number. Maybe how can we frame out that over the next couple o...
Show response
Unmanned grown from $450M to ~$500M. Unique air/ground/subsea portfolio. George: subsea gliders for ASW (long endurance) and Gavia propelled AUVs for mine countermeasures. Demand from Baltic, Black Sea, Asia Pacific. Growth trajectory to be quantified in annual planning cycle.
how much would you attribute that to M&A? And how much would you say is organic this year?
Show response
Most EPS growth organic. M&A contributing ~$0.20-0.25. Acquisitions initially dilutive to margins but improve over time. Standard Teledyne playbook: margin compression at acquisition followed by consistent improvement.
Calendar 2025 Q2
Now as tariffs have deescalated, have you removed any of that kind of contingency from the guide
Show response
Less cautious on tariff-driven demand destruction but contingency not fully removed. 82% intra-regional sales. Supply side: $700M imports facing ~11% = $80M, mitigable to ~$60M ($15M/quarter). Pricing actions available where needed.
were you seeing tangible reductions in orders in like early July that confirms something like this? Or is it more just like something that you're just maybe worried about but aren't seeing evidence...
Show response
No tangible evidence of pull-forward reversal. Pure Teledyne conservatism. Management hopes to confirm pull-forward didn't happen next quarter.
Calendar 2025 Q1
some of the NASA stuff that you have that's more personnel flight control kind of things. What -- like can you talk about the margin profile of the things that are at risk versus the margin profile...
Show response
NASA/space station work at 6-7% margins (lowest in company). Engineered Systems overall ~10% margins. Growing defense space (Golden Dome, satellite-based missile warning) at higher margins. 162 science missions, 1,800 mission years, ~1,000 detectors with zero failures. DOGE reallocation would be margin-positive.
Is the rest of that stuff -- I'm thinking oscilloscopes and environmental kind of environmental equipment. Is that basically at zero now, like with tariffs [145%]
Show response
Not zero but declining. Distributor ordering paused. Chinese competition imitating products and selling cheaper, forcing move upmarket. Dental X-ray already suffered Chinese competition. Half of 2% China export unlikely affected (certified avionics).
Can you kind of go through the backlog with us? I know you mentioned it said all-time highs, but there was also some acquired backlog of some major multiyear stuff you got from Qioptiq.
Show response
~$4B total backlog, $450M Qioptiq (10%). Qioptiq acquired backlog grew $60M from new UK/German MOD contracts. Short-cycle businesses (cameras, environmental) monitored closely as they book-and-ship in 2-4 weeks.
Calendar 2024 Q4
is the dividend at all interesting to you guys to bring in a new class of investors who can't currently invest in the shares?
Show response
No appetite for dividend currently. Prefers M&A given richer pipeline. Buybacks used as alternative cash return when stock was undervalued.
I'm just asking about free cash flow outlook for the year.
Show response
Targeting over $1B again in FY2025 after record $1.11B in FY2024. Lower taxes helped in 2024, plus working capital and advanced program payments that may not recur.
ZBRAZebra Technologies14 questions · 7 reporting periods · 1 of 14 challenging
Calendar 2026 Q2
Is an LTA available to you guys if you wanted to pursue that?
Show response
Winters said Zebra has had supply-agreement discussions with various memory suppliers, but the priority has been qualifying new suppliers and memory types and building short- and long-term visibility, which is playing out. Those discussions are ongoing and are not seen as limiting the company's ability to achieve its outlook; if a long-term agreement were necessary to secure increased supply, the company would pursue one, but it has not been necessary so far.
is the high end of your revenue guidance achievable in the current memory availability framework?
Show response
Burns said the approach for Q3 and full year matches Q2: demand signals point to the high end of the outlook, while the midpoint factors in potential memory supply constraints in the second half. The team executed well delivering above the high end in Q2 by securing additional supply, but with a dynamic and challenging memory environment ahead, the prudent guide sits at the midpoint even though demand supports the high end.
Calendar 2026 Q1
where do you see the sweet spot for you, whether it's developing your own AI tools or having a software partner deploy those tools on a Zebra device
Show response
Burns said Zebra serves as both the data collection infrastructure for AI (asset visibility) and the delivery mechanism for AI outputs (connected frontline). Three-tier approach: Enablers for customers building their own, Blueprints for packaged use cases, Companion for full applications. Meets customers wherever they are in their AI journey. Early stages with multiple pilots and first commercial wins.
in the future, as we have more and more automation and more and more robotics and less people in the buildings that you currently serve, there's just a structural smaller need for your products
Show response
Burns argued automation trends are a tailwind for Zebra. 75% of warehouses still in early automation stages. Even the most advanced customers continue growing their Zebra installed base. Frontline workers projected to increase. Zebra collects data to feed automation and AI models, then delivers outputs to workers. Automation augments workers rather than replacing them.
Calendar 2025 Q4
it is kind of a wide organic growth guide for the year. So maybe you could talk to scenarios and what your visibility looks like
Show response
Winters decomposed the 11% midpoint: ~4pts organic demand, ~5.5pts Elo, ~1.5pts FX. Visibility typical for this time of year. Range bounded around midpoint based on macro conditions and deal timing. Strong pipeline across RFID, manufacturing, and machine vision underpins confidence.
Can you talk about price just like bigger picture? Has the
Show response
Burns said tariffs and memory have made price increases necessary and industry-wide. Customers are price sensitive but also getting significant value through RFID integration, AI capabilities, and enhanced processing. Winters noted pricing was just over half a point of 2025 growth, underlying demand drove the vast majority.
Calendar 2025 Q3
what reasons, if any, would you kind of like talk us off of thinking that next year, at least from where we're sitting now, like shouldn't be at least in the range that you would see in a cycle
Show response
Burns acknowledged customer caution and uneven demand across EMEA and manufacturing. Declined to guide 2026 but expressed confidence in sustainable profitable growth. Deferred to Q1 for formal guidance.
is that element of like we're not baking in much in terms of what we're not seeing directly in the market? Is that still a fair way to categorize
Show response
Winters distinguished from last year: 2024 guide assumed very little year-end spend, which then exceeded expectations. 2025 guide assumes similar year-end spend as actually materialized in 2024. Elo contributing ~$0.10 to full-year EPS. Q4 raise split roughly 1/3 each between lower tariffs, Elo, and interest/share count.
Calendar 2025 Q2
how are you feeling about the ability of your customers to kind of release budgets and kind of move forward with things? Like what do you think is kind of inherent in your guide now in the second half
Show response
Burns said demand is resilient with customers maintaining CapEx. Some spreading spending across quarters. Second half outlook raised based on Q2 results plus backlog and pipeline visibility. Characterized guide as balanced between opportunities and remaining uncertainty.
how does that technology kind of tie in with yours? Like where are they doing things that you couldn't do on your own? What's the customer overlap kind of look like
Show response
Burns positioned Elo as expanding into consumer-facing use cases including point-of-sale, kiosks, and touchscreens. Customer overlap exists in retail but Elo adds strength in quick-serve restaurants. Zebra's global reach will expand Elo beyond North America.
Calendar 2025 Q1
Is there a risk that just, you know, what we think is a lack of a behavior change is just, like, weaker than expected demand is being, like, off is being, like, replenished by some pre-buy
Show response
Burns argued the rapid tariff implementation timeline left minimal opportunity for pre-buying. Winters added that underlying demand is tracking in line with expectations, supporting genuine demand stability.
at least the administration frame this as a temporary exclusion as they figure out, like, specific tariffs on that
Show response
Winters acknowledged semiconductor tariff exposure but said it's unclear how it would be administered. Team is quantifying semiconductor content in products and assessing country-of-origin options.
Calendar 2024 Q4
The free cash flow in the quarter was excellent. I see the guide is at least $750 million
Show response
Burns explained the step-down from 136% to >90% FCF conversion reflects smaller working capital gains and inventory pre-buys ahead of tariffs.
if you were to compare the full year framework and, like, what you're baking in compared to, like, where we were a year ago
Show response
Burns drew parallels to last year's approach but noted different drivers, 2024 was post-destocking recovery while 2025 uncertainty is from trade policy and geopolitics.
ROPRoper Technologies12 questions · 7 reporting periods · 0 of 12 challenging
Calendar 2026 Q2
how many ideas is it taking to generate something that's actually getting into production
Show response
Neil said hit rate is currently high because lower development cost lets them work at higher risk and frenetic pace.
Calendar 2026 Q1
how do you kind of judge the ROI of the investment necessary to kind of -- I say -- maybe not saying to kind of stay in the same place
Show response
Neil cited hard dollar ROIs: DAT load automation $40 vs $100-200 manual, Vertafore reconciliation 30 seconds vs 17 minutes. Jason added using local smaller language models keeps token costs low, and COGS at Vertafore reduced meaningfully in weeks. Very accretive from margin perspective.
Calendar 2025 Q4
were there any instances where like, negative instances where these guys coming in as experts of kind of identified that maybe parts of your business where you thought you had more of an opportunit...
Show response
Neil said overall assessment quite positive on market opportunity and technical prowess. Constructive feedback was around needing to improve quantity of AI talent in businesses, part of why central accelerator team was added. No findings about lack of market opportunity. Jason added Shane and Eddie view vertical specificity as very unique versus horizontal players.
how are you weighing you know, something that like, the certainty of what you know versus, like, the risk-reward of something you don't know at the price that you're paying?
Show response
Neil said valuation dislocation is 'silly' and they leaned in on Q4 buyback, find it more attractive today. But M&A remains a real lever, described commentary questioning M&A thesis as 'absurd.' Pipeline enormous, LP pressure legit, Roper is preferred buyer. Jason added increased AI conviction from operating plan reviews.
Calendar 2025 Q3
what in your sense is like really the catalyst to bring this into like a high single to -- more of like a high single framework?
Show response
Neil identified multiple catalysts: Deltek GovCon normalizing, CentralReach turning organic, Frontline reaccelerating as DOE/COVID funding normalizes, Clinisys U.S. turning mid-single digit growth after 8-year lag. AI opportunity at Vertafore with early green shoots next year.
what's the thought process when you're weighing like, okay, here's a $1 billion opportunity here or $1 billion of deploying capital
Show response
Neil said decision framework is always about optimizing long-term cash flow compounding, not stock multiple. Buyback is simply another lever in the consideration set alongside M&A.
Calendar 2025 Q2
can you talk about the market landscape there a little bit in the competitive landscape? I mean, I guess it doesn't feel like a structural growing market
Show response
Neil sized TAM at $2.5B, 50% served. Church attendance flat, buildings up low single digits, giving up 4-5% over 10-20 years. Digitization drives ~9% market growth. 50% of donations still cash/check.
like how do you kind of prevent similar things from happening. I know they're totally different markets
Show response
Neil's key learning: act immediately when challenges surface. Jason added improved diligence staffing and telemetry. Transact and CentralReach tracking well on value creation plans.
Calendar 2025 Q1
your small beat in the quarter versus guide, hold do organic. You absorbed $0.15 and still raising. Like is there kind of a contingency
Show response
Jason explained Q1 beat flowed through plus removal of margin and interest contingency from prior guide, offsetting CentralReach dilution to arrive at modest raise.
has that been primary DOGE risk kind of like done now? Like if Musk is going back to Tesla and we haven't seen these big changes
Show response
Neil broadened beyond DOGE to include budget uncertainty, shutdown risk, and debt ceiling. Noted DOGE appears stuck at $160-170B savings, Musk spending time elsewhere, and essential nature of contractor services.
Calendar 2024 Q4
people are a little concerned there might be some sort of headwinds just from a US policy standpoint could be like the GovCon piece of Deltek
Show response
Neil acknowledged uncertainty but noted DOGE principles (accountability, performance-based pricing, modernization) align with Deltek strengths. GovCon bookings in Q3/Q4 remained robust.
I was wondering if there's a way to quantify either in terms of ability to price differently and charge for new capabilities
Show response
Neil acknowledged AI impact is hard to quantify mathematically in 2024 but cited bookings halo effects at Aderant and Deltek and productivity gains in customer support.
TELTE Connectivity7 questions · 7 reporting periods · 1 of 7 challenging
Calendar 2026 Q2
it suggests that like the rest of DDN, that $800 million of more traditional stuff isn't growing that fast this year
Show response
Terrence acknowledged the classification blurs by customer and that non-AI areas see smaller (sometimes negative) growth as investment shifts to AI workloads; partial quantification.
Calendar 2026 Q1
how do we think about like the price inherent in the orders versus the price that's coming through in P&L? Like is there a real lag there?
Show response
Heath confirmed no pull-forward activity or customers trying to get ahead of price increases. Orders are project-based from pipeline, distribution is hand-to-mouth and consistent. CapEx running at 6% of revenue, increase almost entirely for AI program ramps tied to specific customer awards. Capital investments provide protection given awarded programs.
Calendar 2025 Q4
we've just seen like metal price is exploding here, copper, gold, silver. Can you talk about implications for you guys in terms of procurement, in terms of needing to pass cost on and what the cust...
Show response
Heath confirmed metals inflationary pressure as largest purchase category. Team leveraging supply chain investments for scale and sourcing. Passing through quickly via pricing with improved agility vs prior cycles. Will not use metals inflation as excuse on margins or flow-through math.
Calendar 2025 Q2
how was that in the quarter end? And just curious how you think about that going forward
Show response
Terrence noted tariff costs came in at 1.5% vs 3% expected due to policy changes. No earnings impact. Q4 assumes similar level. Underlying pricing driven by material costs, positive in Industrial, neutral overall.
Calendar 2025 Q1
are you just still seeing kind of a pause in customers wanting to move forward with things until they know what the rules of engagement are
Show response
Terrence acknowledged tariff uncertainty is distracting from capex decisions. Same people working automation plans are now focused on supply chain re-routing. Taking cautious view despite seeing U.S. automation orders pick up.
Calendar 2024 Q4
I know you've mentioned orders suggest stabilization. Are you seeing any evidence of, like, that orders need to kind of ramp from here
Show response
Terrence said industrial equipment is stabilized with sequential improvement expected. Medical decline was one-time inventory normalization; orders already showing book-to-bill well above 1.
Calendar 2024 Q3
you're getting a lot of announcements in Germany about workers at auto facilities joining nationwide strikes
Show response
Terrence confirmed known risks embedded in guidance. Expects Q1 global auto production down similar to Q4, with Europe weakness offset by Asia growth.
AMEAmetek6 questions · 3 reporting periods · 1 of 6 challenging
Calendar 2026 Q1
There seems to be emerging concerns that potentially aerospace aftermarket, I guess, on the commercial side is peaking
Show response
Zapico noted third-party aftermarket is less than 2% of sales. U.S. remains strong with retrofit programs. Weakness would likely appear first in Asia, then Europe, with U.S. most insulated.
Can you talk about like where -- what you guys are doing there on semis and how that business is sitting in
Show response
Zapico explained Abaco sells advanced computing technology to semiconductor tool manufacturers ramping for AI demand, alongside its core defense computing business.
Calendar 2025 Q4
Could you maybe give us a little color on the new deal
Show response
Smaller technology deal, terms not disclosed. Leading provider of portable ophthalmic diagnostic instruments for detecting diabetic retinopathy via electrical response. ~60 employees near DC. ~40% recurring revenue from sensor strips. Fits into Ultra Precision Technologies/Ryker business.
a little conservative, low single digit coming off like an acceleration throughout the year
Show response
Q4 was first positive quarter for process in 2025, being prudent. Positives: semiconductor, metals, instrumentation. Slightly weaker: oil & gas and research. One quarter doesn't make a year.
Calendar 2024 Q4
can you kind of do your walk with like the 2024 actual and like the View?
Show response
Process: low single digit growth in 2025. A&D: mid-single digits. Power & Industrial: flat. Automation & Engineered Solutions: up mid-single digits with improving trends.
Did you give the actual order number or the book to bill for the quarter?
Show response
Organic orders +4%, book-to-bill 1.01 ex-FX. Both EIG and EMG positive with EMG slightly stronger.
Show 5 more companies
FTVFortive6 questions · 4 reporting periods · 1 of 6 challenging
Calendar 2025 Q3
Where do you see recurring revenue potentially ending up as a percent of total in the longer term?
Show response
No ceiling set on recurring revenue target. Fluke is biggest lever, went from ~0% to 15% recurring over 10 years. Hardware-as-a-service at Industrial Scientific provides template. Recurring customer value is one of three Fortive Accelerator pillars.
Calendar 2025 Q2
Does this push them towards like more down the line to single-use applications
Show response
Soroye argued hospitals will drive more activity through ORs (profit center), requiring advanced devices like robotics and endoscopes that need ASP-style sterilization. Single-use has disadvantages in effectiveness and total cost. Recent hospital customer visits confirmed increased need for ASP.
what the -- like the appetite is on the software side, just given where the multiple of the stock is
Show response
No hard line between software and hardware M&A. All must meet same strategic and financial criteria including accretive pricing compatible with stock multiple. Proprietary deal cultivation over years, not banker-led processes. Will hold to criteria without compulsion.
Calendar 2025 Q1
Can you talk us through the -- like where they're manufacturing and how that compares to competition?
Show response
Tek has global manufacturing flexibility. IP-protected products may move to NATO countries. Accelerating existing supply chain migration plans aligned with product launch cadence.
on the core growth side I doubt anyone had 2.5. Like was that below what you guys were thinking?
Show response
AHS came in right where expected. Adding back the two fewer days puts underlying growth in mid-single-digit range. Math was straightforward from Q4 guidance.
Calendar 2024 Q4
do you think you guys have just more structural exposure to things like EB in China than some of your competitors do?
Show response
EA may have slightly more EV exposure than peers, but multi-year performance benchmarks are similar. PT margins impacted by volume decline and mix in higher-margin businesses.
PNRPentair6 questions · 4 reporting periods · 1 of 6 challenging
Calendar 2026 Q1
can you talk about how much this causes a lock-in of equipment?
Show response
CEO distinguished premium pool automation (high lock-in, product optimization) from simple on/off controls (more commoditized). Plans low-end automation solution in 2027.
your performance in Pool versus your biggest channel partner, historically it was a tight relationship
Show response
CFO clarified largest partner's sell-through tracks PNR equipment performance but sell-in diverged due to channel pre-buying. Realignment expected Q2-Q3.
Calendar 2025 Q3
we're hearing a little bit more about like, dealer or dealers and installers kinda using some more foreign products. And some like, low-cost products maybe from Asia
Show response
CEO acknowledged emergence of low-cost foreign alternatives. Not a huge short-run impact but requires focus on innovation, quality, and brand differentiation. Currently concentrated in commodity/non-intelligent products.
Targeted to a specific type of application set or product type, or is it kind of pervasive?
Show response
CEO specified low-cost substitution is concentrated in commodity products: lower-end filters in pool, basic filtration across businesses. Intelligent/connected products are harder to substitute.
Calendar 2025 Q2
you mentioned like price and pool up 15% in trailing 12 months. Just curious like, is that creating an opportunity for foreign product to come in
Show response
CEO acknowledged hearing about foreign competition on low-end dummer products but not seeing it yet. Believes automation and IoT connectivity create moat. Could become issue if volumes don't recover.
Calendar 2025 Q1
on these price increases, are they different than normal ones? Like, how specifically tied are they to tariffs?
Show response
CEO confirmed prices are broad-based, not tariff surcharges. Phased 30-day increments allow reaction to changing environment. 75% actioned, 25% coming.
APHAmphenol5 questions · 5 reporting periods · 1 of 5 challenging
Calendar 2026 Q2
But what are the implications of how that mix ultimately plays out globally?
Show response
Norwitt said Amphenol is not dependent on model type, training versus inference, or geography, and noted inference appears to grow faster and is interconnect intensive.
Calendar 2026 Q1
as you get into these more complex, more streamlined types of architectures like the interplay between what the value of those products are versus like what might be going away
Show response
Norwitt pivoted to power interconnect opportunity rather than quantifying the ASP vs volume trade-off. Highlighted broad power product portfolio but couldn't provide specific metrics.
Calendar 2025 Q4
what does, like, the know, if you think through the potential positives and negatives for such a dynamic
Show response
Norwitt said technology transitions drive more complexity which benefits Amphenol regardless of specific direction. With CommScope adding fiber capabilities, Amphenol now has broadest offering to support all interconnect trade-offs customers face.
Calendar 2025 Q2
just curious if your business there is getting more concentrated or less concentrated from a customer standpoint
Show response
Norwitt confirmed broad customer base across hyperscalers, OEMs and chip companies. Averaging Q2/Q3 shows stable performance with future growth expected.
Calendar 2025 Q1
Like how would you know? Like what is the possibility, because I feel like a lot of channel checks that people have done suggest there is pull-in
Show response
Norwitt acknowledged the possibility of unseen pull-in but pointed to distribution channel showing only low single-digit sequential growth as evidence against meaningful pre-buying.
PHParker Hannifin2 questions · 2 reporting periods · 2 of 2 challenging
Calendar 2026 Q2
how consistent is that with where order rates were for you by those end markets for '26?
Show response
Said the FY27 end-market guide is consistent with Q4 order exit rates (Q1 guided slightly above the Q4 exit) and denied any pull-forward of orders into Q4.
Calendar 2024 Q3
what are the things that you're on the lookout to see like all right these delays are going to like extend indefinitely
Show response
Parmentier said Parker sees delays rather than cancellations, watching plant shutdowns and production schedules; the backlog is steady and it feels like a pause, not a downturn.
XYLXylem Inc.1 question · 1 reporting period · 0 of 1 challenging
Calendar 2025 Q1
can you just talk me through the the sequential dynamics in margin at NCS from 4Q to 1Q?
Show response
Q4 had one-timers like incentive true-ups masking margin. Q1 cleaner. Q2 goes down then sequential improvement from Q3.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| IEX IDEX Corporation | 14 | 50%7 of 14 questions |
| TDY Teledyne Technologies | 14 | 7%1 of 14 questions |
| ZBRA Zebra Technologies | 14 | 7%1 of 14 questions |
| ROP Roper Technologies | 12 | 0%none of 12 questions |
| TEL TE Connectivity | 7 | 14%1 of 7 questions |
| AME Ametek | 6 | 17%1 of 6 questions |
| FTV Fortive | 6 | 17%1 of 6 questions |
| PNR Pentair | 6 | 17%1 of 6 questions |
| APH Amphenol | 5 | 20%1 of 5 questions |
| PH Parker Hannifin | 2 | —Rate withheld: fewer than 3 questions |
- IEXIDEX Corporation · 14 questions50%7 of 14 questions
- TDYTeledyne Technologies · 14 questions7%1 of 14 questions
- ZBRAZebra Technologies · 14 questions7%1 of 14 questions
- ROPRoper Technologies · 12 questions0%none of 12 questions
- TELTE Connectivity · 7 questions14%1 of 7 questions
- AMEAmetek · 6 questions17%1 of 6 questions
- FTVFortive · 6 questions17%1 of 6 questions
- PNRPentair · 6 questions17%1 of 6 questions
- APHAmphenol · 5 questions20%1 of 5 questions
- PHParker Hannifin · 2 questions—rate withheld: under 3 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2024 Q3 | 2 | 50%1 of 2 questions | 2 |
| 2024 Q4 | 12 | 8%1 of 12 questions | 7 |
| 2025 Q1 | 15 | 20%3 of 15 questions | 9 |
| 2025 Q2 | 13 | 15%2 of 13 questions | 8 |
| 2025 Q3 | 11 | 9%1 of 11 questions | 6 |
| 2025 Q4 | 12 | 0%none of 12 questions | 7 |
| 2026 Q1 | 12 | 25%3 of 12 questions | 8 |
| 2026 Q2 | 10 | 50%5 of 10 questions | 7 |
- 2024 Q32 questions · challenge rate 50% (1 of 2 questions) · 2 companies
- 2024 Q412 questions · challenge rate 8% (1 of 12 questions) · 7 companies
- 2025 Q115 questions · challenge rate 20% (3 of 15 questions) · 9 companies
- 2025 Q213 questions · challenge rate 15% (2 of 13 questions) · 8 companies
- 2025 Q311 questions · challenge rate 9% (1 of 11 questions) · 6 companies
- 2025 Q412 questions · challenge rate 0% (none of 12 questions) · 7 companies
- 2026 Q112 questions · challenge rate 25% (3 of 12 questions) · 8 companies
- 2026 Q210 questions · challenge rate 50% (5 of 10 questions) · 7 companies
Topics
Topics tagged on this analyst’s questions.
- Demand36
- Competitive Dynamics22
- Revenue Growth17
- Guidance Reliability14
- Cloud & AI12
- Trade Tariffs11
- Innovation & R&D10
- M&A10
- Pricing8
- Capital Allocation7
Show all 19 topics
- Margin5
- Regulation Policy5
- Supply Chain3
- Capex Investment2
- Inventory2
- Cost Pressure2
- Macroeconomic2
- Geographic Expansion1
- Labor Market1